Takeda clears key hurdle as investors back $59 billion Shire deal
2018-12-5 05:48 pm
Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.
Read The Rest at
Russia's Gazprom Neft sticking with plan to...
Unilever's Polman calls for trust in farewell...
You May Also Like
Those back in Bihar don’t need to leave out of...
LVMH wants to renegotiate $16.2 billion Tiffany...
Exclusive: Ex-Enron CEO Skilling launching new...
Bhad Bhabie announces she's entered treatment...
MLS, players reach new labor deal, resume with...
Business Insight | Moody#39;s downgrades SBI,...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version